Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: FEBS J. 2019 Jun 21;286(20):4036–4059. doi: 10.1111/febs.14954

Table 6.

Bacterial strains used in this study.

Strains Characteristics References
P. aeruginosa PA14 Clinical isolate UCBPP-PA14 [89]
PA14_ rhlA::MrT7 Inactivation of rhlA in PA14 (rhlA::MrT7) (polar mutant) [90]
B. glumae BGR1 Wild-type, RifR [91]
B. glumae BGR1 rhlA Deletion of rhlA in BGR1 (polar mutant) [92]
E. coli DH5α supE44 ΔlacU169 (Φ80lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Invitrogen
E. coli 5-alpha DH5α derivate. fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 NEB